Injections Caring for Carcinoid Foundation奥曲肽注射关注类癌的基础课件.ppt

Octreotide Injections April Boyd, RN Octreotide therapy Used to treat carcinoid syndrome Diarrhea Flushing (reddening of face and neck) Dosing Your oncologist will prescribe the dose best for you considering your Symptoms experienced Tolerance of therapy Short-acting octreotide Test dose Subcutaneous (under the skin) As needed or “break through” use Self injection Octreotide LAR Monthly injection Alternating site of injection Dose changes Injection preparation Refrigeration Mixing Administration Communication Gluteal injection Gluteal (buttock) muscle Posture Preparation Site selection Dis-robing Pressure Injection comfort A good walk Local gentle pressure or slight massage Over the counter products such as ibuprofen (Advil) or acetaminophen (Tylenol) Bleeding concerns Communication with Health Care Provider Injection tolerance Side effects New symptoms Intramuscular vs. subcutaneous injection Gastrointestinal Center Project Injection success tips Allow for adequate time and preparation Allow for thorough evaluation of injection site Ask questions and provide feedback Understand immediate and therapeutic goals Intramuscular injection Symptom control Long term use Pancreatic insufficiency Floating or oily stools Pancreatic enzymes Gall stones/ gallbladder sludge Blood glucose monitoring Insurance coverage FDA label includes carcinoid syndrome and VIPoma NCCN compendia includes depot octreotide for metastatic non-functional carcinoids Billing codes Business Center